IPO proceeds in 2018 plunged by 49% to Rs4.8 billion
AGP Pharmaceutical, one of the largest companies in the country’s pharmaceutical sector via its offer for sale (OFS) collected 65% of total raised capital during 2018
Liven Pharmaceuticals just made a rights issue. Will this prove to be the last throw of the dice?
The pharmaceutical company has had a torrid history. The new development could prove to be its redemption
As Panadol prices stabilise, Haleon’s revenue growth slows
The boost from deregulated drug prices is stalling, causing Haleon to look at new product launches in nutraceuticals and export markets for growth
The magic pill for the pharma sector
Will the deregulation in drug pricing policy prove to be the long awaited cure for the pharmaceutical industry?
Highnoon Laboratories partners with Bangladesh-based Beximco Pharmaceuticals for strategic collaboration
Both firms sign MoU to distribute and market specialised pharmaceutical products in Pakistan, focusing on key therapeutic areas
Drug price deregulation has come to Pakistan. What will this mean?
Companies can finally raise prices, which is likely to result in higher prices, but also likely to mean fewer shortages of essential drugs
Pakistan’s pharmaceutical exports hit 34% growth in FY25, marking a two-decade high
Exports of locally produced medicines reach $457 million, with deregulation policy boosting growth
UK report claims Pakistan’s Covid-19 medicine enough for national demand
Pakistan, along with India, is the only one among developing countries to have effectively stored enough of Remdesivir to meet their national demands of...
Pakistan to import insulin from Russia through pharmaceutical joint ventures
Joint ventures to strengthen insulin supply, with focus on local manufacturing and price regulation
Pakistan’s retail pharma sector surpasses Rs1.049 trillion in sales
Data from IQVIA reveals steep price hikes drive growth as medicine consumption shows minimal increase, raising concerns over affordability
Pakistan loses up to Rs50bn annually to unethical drug marketing, say DRAP officials
DRAP CEO says irrational drug use accounts for nearly a quarter of Pakistan’s total health budget and is accelerating antimicrobial resistance
Pak pharma industry suffers from government’s shackles
A thriving sector in Pakistan’s economy, pharmaceuticals is a $3.2 billion industry, growing at 15% annually, while its exports now at $US200 million are...
Despite deregulated prices, Searle swings to a loss
Price increases were not enough to compensate for increases in operating costs, despite a gross profit margin expansion
Medicinal imports rise 3.54pc to $929m
ISLAMABAD: Pakistan has imported medicinal products worth $929.355 million during the first ten months of the current fiscal year, showing a growth of 3.54pc, as...
Pfizer looks beyond COVID sales with $43b deal for cancer drugmaker Seagen
WASHNGTON: Pfizer Inc on Monday struck a roughly $43 billion deal for Seagen Inc to bulk up its cancer treatments portfolio, as the drugmaker...
